Aclarion
$0.23
20
-$0-1.74% Friday 20:56
Statistics
Day High
-
Day Low
-
52W High
2.37
52W Low
0.23
Volume
28,177
Avg. Volume
275,116
Mkt Cap
1.99M
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
29NovExpected
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q3 2023
-1.35
-0.9
-0.45
0
Expected EPS
-0.09
Actual EPS
0
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ACON. It's not an investment recommendation.
About
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Show more...
CEO
Employees
3
Country
US
ISIN
US6551871022